Evaluating the mTOR Pathway in Physiological and Pharmacological Settings

Methods in Enzymology

Volumn 587, Issue , 2017, Pages 405-428

  Hong, S ^a   Inoki, K ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autophagy; mTOR; mTORC1; mTORC2; Rag; Rapamycin; Rheb; Translation; TSC

Indexed keywords

CALCIUM PHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MTOR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; NEUROPEPTIDE; RHEB PROTEIN, HUMAN; SERINE THREONINE PROTEIN KINASE ULK1; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; ANIMAL; AUTOPHAGY; CELL CULTURE TECHNIQUE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; PROCEDURES; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN-1 HOMOLOG; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MONOMERIC GTP-BINDING PROTEINS; MULTIPROTEIN COMPLEXES; NEUROPEPTIDES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSFECTION;

EID: 85013845996     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/bs.mie.2016.09.068     Document Type: Chapter

References (53)

1. Bar-Peled, L., Chantranupong, L., Cherniack, A.D., Chen, W.W., Ottina, K.A., Grabiner, B.C., et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340 (2013), 1100–1106.
2. Bar-Peled, L., Schweitzer, L.D., Zoncu, R., Sabatini, D.M., Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150 (2012), 1196–1208.
3. Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 (1994), 756–758.
4. Cargnello, M., Tcherkezian, J., Roux, P.P., The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis 30 (2015), 169–176.
5. Carroll, B., Maetzel, D., Maddocks, O.D., Otten, G., Ratcliff, M., Smith, G.R., et al. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. eLife, 5, 2016.
6. Chantranupong, L., Scaria, S.M., Saxton, R.A., Gygi, M.P., Shen, K., Wyant, G.A., et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165 (2016), 153–164.
7. Chantranupong, L., Wolfson, R.L., Orozco, J.M., Saxton, R.A., Scaria, S.M., Bar-Peled, L., et al. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Reports 9 (2014), 1–8.
8. Demetriades, C., Doumpas, N., Teleman, A.A., Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 156 (2014), 786–799.
9. Dibble, C.C., Cantley, L.C., Regulation of mTORC1 by PI3K signaling. Trends in Cell Biology 25 (2015), 545–555.
10. Dibble, C.C., Elis, W., Menon, S., Qin, W., Klekota, J., Asara, J.M., et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Molecular Cell 47 (2012), 535–546.
11. Dibble, C.C., Manning, B.D., Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nature Cell Biology 15 (2013), 555–564.
12. Feldman, M.E., Apsel, B., Uotila, A., Loewith, R., Knight, Z.A., Ruggero, D., et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biology, 7, 2009, e38.
13. Garami, A., Zwartkruis, F.J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Molecular Cell 11 (2003), 1457–1466.
14. Gaubitz, C., Oliveira, T.M., Prouteau, M., Leitner, A., Karuppasamy, M., Konstantinidou, G., et al. Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2. Molecular Cell 58 (2015), 977–988.
15. Geissler, E.K., Post-transplantation malignancies: Here today, gone tomorrow?. Nature Reviews. Clinical Oncology 12 (2015), 705–717.
16. Guertin, D.A., Sabatini, D.M., Defining the role of mTOR in cancer. Cancer Cell 12 (2007), 9–22.
17. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 (2002), 177–189.
18. Hsieh, A.C., Liu, Y., Edlind, M.P., Ingolia, N.T., Janes, M.R., Sher, A., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485 (2012), 55–61.
19. Inoki, K., Li, Y., Xu, T., Guan, K.L., Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes & Development 17 (2003), 1829–1834.
20. Inoki, K., Li, Y., Zhu, T., Wu, J., Guan, K.L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biology 4 (2002), 648–657.
21. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y., et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127 (2006), 125–137.
22. Jewell, J.L., Kim, Y.C., Russell, R.C., Yu, F.X., Park, H.W., Plouffe, S.W., et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 347 (2015), 194–198.
23. Jewell, J.L., Russell, R.C., Guan, K.L., Amino acid signalling upstream of mTOR. Nature Reviews. Molecular Cell Biology 14 (2013), 133–139.
24. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T.P., Guan, K.L., Regulation of TORC1 by Rag GTPases in nutrient response. Nature Cell Biology 10 (2008), 935–945.
25. Kim, J., Kundu, M., Viollet, B., Guan, K.L., AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 13 (2011), 132–141.
26. Kim, J.S., Ro, S.H., Kim, M., Park, H.W., Semple, I.A., Park, H., et al. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Scientific Reports, 5, 2015, 9502.
27. Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 (2002), 163–175.
28. Laplante, M., Sabatini, D.M., mTOR signaling in growth control and disease. Cell 149 (2012), 274–293.
29. Lizcano, J.M., Goransson, O., Toth, R., Deak, M., Morrice, N.A., Boudeau, J., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. The EMBO Journal 23 (2004), 833–843.
30. Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J., Cantley, L.C., Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Molecular Cell 10 (2002), 151–162.
31. Menon, S., Dibble, C.C., Talbott, G., Hoxhaj, G., Valvezan, A.J., Takahashi, H., et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156 (2014), 771–785.
32. Moschetta, M., Reale, A., Marasco, C., Vacca, A., Carratu, M.R., Therapeutic targeting of the mTOR-signalling pathway in cancer: Benefits and limitations. British Journal of Pharmacology 171 (2014), 3801–3813.
33. Nakashima, N., Noguchi, E., Nishimoto, T., Saccharomyces cerevisiae putative G protein, Gtr1p, which forms complexes with itself and a novel protein designated as Gtr2p, negatively regulates the Ran/Gsp1p G protein cycle through Gtr2p. Genetics 152 (1999), 853–867.
34. Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136 (2009), 521–534.
35. Oshiro, N., Rapley, J., Avruch, J., Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging. The Journal of Biological Chemistry 289 (2014), 2658–2674.
36. Parmigiani, A., Nourbakhsh, A., Ding, B., Wang, W., Kim, Y.C., Akopiants, K., et al. Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Reports 9 (2014), 1281–1291.
37. Peterson, T.R., Laplante, M., Thoreen, C.C., Sancak, Y., Kang, S.A., Kuehl, W.M., et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137 (2009), 873–886.
38. Potter, C.J., Pedraza, L.G., Xu, T., Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biology 4 (2002), 658–665.
39. Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., Sabatini, D.M., Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141 (2010), 290–303.
40. Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 (2008), 1496–1501.
41. Sancak, Y., Thoreen, C.C., Peterson, T.R., Lindquist, R.A., Kang, S.A., Spooner, E., et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Molecular Cell 25 (2007), 903–915.
42. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 22 (2006), 159–168.
43. Sarbassov, D.D., Guertin, D.A., Ali, S.M., Sabatini, D.M., Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005), 1098–1101.
44. Sekiguchi, T., Hirose, E., Nakashima, N., Ii, M., Nishimoto, T., Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. The Journal of Biological Chemistry 276 (2001), 7246–7257.
45. Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 3329–3335.
46. Su, B., Jacinto, E., Mammalian TOR signaling to the AGC kinases. Critical Reviews in Biochemistry and Molecular Biology 46 (2011), 527–547.
47. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y., et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. The Journal of Biological Chemistry 284 (2009), 8023–8032.
48. Vander Haar, E., Lee, S.I., Bandhakavi, S., Griffin, T.J., Kim, D.H., Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nature Cell Biology 9 (2007), 316–323.
49. Wolfson, R.L., Chantranupong, L., Saxton, R.A., Shen, K., Scaria, S.M., Cantor, J.R., et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351 (2016), 43–48.
50. Wullschleger, S., Loewith, R., Hall, M.N., TOR signaling in growth and metabolism. Cell 124 (2006), 471–484.
51. Yang, Q., Inoki, K., Ikenoue, T., Guan, K.L., Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes & Development 20 (2006), 2820–2832.
52. Zhang, Y., Gao, X., Saucedo, L.J., Ru, B., Edgar, B.A., Pan, D., Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nature Cell Biology 5 (2003), 578–581.
53. Zinzalla, V., Stracka, D., Oppliger, W., Hall, M.N., Activation of mTORC2 by association with the ribosome. Cell 144 (2011), 757–768.